首页> 外文期刊>Internet Journal of Hematology >Acral Erythema associated with Irradiated Blood Transfusion in Myelodysplastic Syndrome: A Case Report
【24h】

Acral Erythema associated with Irradiated Blood Transfusion in Myelodysplastic Syndrome: A Case Report

机译:脊髓增生异常综合征伴有辐射性输血的急性红斑:一例报告

获取原文
           

摘要

Acral erythema (AE) is a known chemotherapy-induced adverse cutaneous reaction that has been described in association with a number of different chemotherapeutic agents. The most common agents implicated in this reaction are cytarabine, doxorubicin, and fluorouracil. This disorder has also been described in association with graft versus host disease (GVHD) related to solid organ and bone marrow transplantation. An association with blood transfusion has only been described in transfusion- related GVHD. The skin reaction consists of painful intense macular erythema of palms and soles. It may be followed by blister formation and skin necrosis and usually heals uneventfully with desquamation of the skin. We describe a case of an 88 year old female with myelodysplastic syndrome (MDS) who presented with red, swollen and painful macular rash on both palms and soles after receiving leukocyte depleted, irradiated packed red blood cells 2 days prior. We found no description in the medical literature of AE to be associated with blood transfusion in the absence of GVHD. Introduction Acral erythema (AE), also known as hand-foot syndrome, palmo-planta erythrodyesthesia, and toxic erythema of palms and soles, was first reported by Zuehlk in 1974 in association with mitotane therapy [1]. Several chemotherapy-induced clinical and histologic changes of the area have been reported in the past decade because of new chemotherapeutic drugs, better recognition of histologic reaction patterns, and the prescription of higher dosages by oncologists. Since then, AE has been described as a side effect of many chemotherapeutic agents. Drugs implicated most commonly include doxorubicin [2], methotrexate [3], 5-flourouracil [4], cytosine arabinoside [5], and hydroxyurea [6]. A distinctive acral erythema has been depicted in patients with myelogenous leukemia, subsequent to blood transfusions and intensive chemotherapy with cytarabine [5]. Other reports have also linked AE to GVHD related to bone marrow and solid organ transplantation [7]. Prior association of AE association with blood transfusion was only described in the setting of transfusion related GVHD [8,9]. We report a case of AE associated with irradiated blood transfusion in the absence of GVHD. Case report An 88-year-old Caucasian female with a history of transfusion dependent myelodysplastic syndrome (MDS) of 8 months duration presented with red, swollen and painful intense macular erythema of the palms and soles. Since the diagnosis of MDS, the patient received 10 units of irradiated, leukocyte-depleted packed red cells with no complications or adverse events. Benadryl was routinely administered prior to transfusion to prevent transfusion reactions,. The patient had a history of coronary artery disease, and her angina was occasionally exacerbated with worsening of anemia. She was on extended release metoprolol, isosorbide dinitrate, and enteric coated aspirin for angina and hypertension. No new medications were started before this presentation and she had no known drug or food allergies. She was given 2 units of irradiated, leukocyte depleted, packed red blood cell transfusion two days prior to admission without premedication with benadryl to avoid sedation. After transfusion of the second unit, she developed fever, acral tingling, pruritis, burning sensation and pain followed by a rash only in the acral area (Figures 1 and 2). Physical examination revealed a temperature of 38.5?C, pulse 96 per minute, respiratory rate 18 per minute and blood pressure of 146/46 mm/Hg. Both palms were red, edematous, and tender with erythema extending up to the forearms. There was marked tenderness, erythema and edema of both feet, with turbid bullae on the soles. The skin lesions progressed to necrosis in some areas. The remainder of the physical examination was unremarkable, except for radiologically persistent (clinically not significant) bilateral lung infiltrates due to a recently treated bacterial pneumonia
机译:急性红斑(AE)是一种已知的化学疗法诱导的不良皮肤反应,已与多种不同的化学治疗剂结合进行了描述。与该反应有关的最常见药物是阿糖胞苷,阿霉素和氟尿嘧啶。还已经与与实体器官和骨髓移植有关的移植物抗宿主病(GVHD)相关联描述了该疾病。仅在与输血有关的GVHD中描述了与输血的关系。皮肤反应包括手掌和脚底的强烈黄斑性红斑。随后可能会形成水疱和皮肤坏死,并且通常会因皮肤脱屑而不适当地愈合。我们描述了一个88岁女性患有骨髓增生异常综合症(MDS)的病例,该患者在2天前接受白细胞耗竭,照射后的充血红细胞后,在手掌和足底均出现了红色,肿胀和疼痛的黄斑皮疹。我们发现在缺乏GVHD的情况下,AE的医学文献中没有与输血相关的描述。简介1974年,Zuehlk首次报道了伴有米线烷疗法的急性红斑(AE),也称为手足综合征,手掌红斑,手掌和足底毒性红斑[1]。在过去的十年中,由于新的化学治疗药物,对组织学反应模式的更好识别以及肿瘤科医生开出更高剂量的处方,已经报道了该地区由化学疗法引起的临床和组织学变化。从那时起,AE被描述为许多化疗药物的副作用。最常见的药物包括阿霉素[2],氨甲蝶呤[3],5-氟尿嘧啶[4],阿糖胞苷[5]和羟基脲[6]。输血和阿糖胞苷强化化疗后,骨髓性白血病患者出现了明显的急性红斑[5]。其他报道也将AE与与骨髓和实体器官移植相关的GVHD相关联[7]。仅在与输血有关的GVHD的背景下描述了AE与输血相关的先前关联[8,9]。我们报道了在没有GVHD的情况下,与辐射性输血相关的AE病例。病例报告一名88岁的白人女性,有8个月的输血依赖性骨髓增生异常综合症(MDS)病史,手掌和足底出现红色,肿胀和疼痛的强烈黄斑性红斑。自诊断出MDS以来,该患者接受了10单位辐照的,耗尽白细胞的堆积红细胞,没有并发症或不良事件。 Benadryl在输血前常规给药,以防止输血反应。该患者有冠状动脉疾病病史,其心绞痛有时因贫血加重而加重。她正在服用美托洛尔,硝酸异山梨酯和肠溶性阿司匹林缓释剂,以治疗心绞痛和高血压。在本次演讲之前没有开始任何新的药物治疗,她没有已知的药物或食物过敏。在入院前两天,给她2单位经辐射,耗竭的白细胞,充血的红细胞输注,且未预先使用苯达地尔进行预防性镇静。第二单位输血后,她发烧,肢端刺痛,瘙痒,烧灼感和疼痛,然后仅在肢端区域出现皮疹(图1和2)。体格检查发现温度为38.5℃,每分钟脉搏96,呼吸频率为每分钟18,血压为146/46 mm / Hg。两手掌均为红色,水肿,并有红斑,延伸至前臂。双脚有明显的压痛,红斑和水肿,鞋底混浊大疱。皮肤病变在某些区域发展为坏死。其余的体格检查无异常,除了由于最近治疗过的细菌性肺炎而导致放射学上持久的(临床上不明显)双侧肺浸润

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号